Device Trial Radar · NCT01325792
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Last checked: Nov 19, 2026Latest source record: Dec 24, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
104
Actual
Start
Feb 2011
Primary completion
Dec 2014
Study completion Dec 2014
Sponsor
- Lead sponsor
- W.L.Gore & AssociatesNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 30, 2011
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Prospective, multicenter, observational study to evaluate performance of GORE® BIO-A® Tissue Reinforcement when used to reinforce midline fascial closure in single-staged open complex ventral incisional hernia repair.
Conditions
- Ventral Incisional Hernia
Interventions
GORE® BIO-A® Tissue ReinforcementDevice
Retrorectus or intraperitoneal placement of device to reinforce the midline fascial closure after single-staged open complex ventral incisional hernia repair of primary or recurrent anterior abdominal wall hernia.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Hernia Recurrence RateTime frame: at about 24 months
Locations
9 sites in 2 countries. Site status is shown where the registry gives one.
UCSD Department of Surgery
San Diego, California
Indiana University
Indianapolis, Indiana
Washington University
St Louis, Missouri
6 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.